Dextro<wbr/>methorphan (hydrobromide hydrate)

Dextromethorphan (hydrobromide hydrate)

CAT N°: 13950

Dextromethorphan (DXM) is a dextratrorotatory morphinan with structural similarity to levorphanol, codeine, and morphine. Because of its strong antitussive effects, dextromethorphan is widely used as a cough suppressant.{21979} However, it does not provoke opioid activity as is characteristic of several other morphine derivatives. DXM binds to and inhibits NMDA (IC50 = 0.55 ?M) and nicotinic receptors (IC50s = 0.7-3.9 ?M) and blocks receptor-gated and voltage-gated calcium channels (IC50 = 60 ?M) and voltage-gated sodium channels (IC50 = 78 ?M).{21979,21978,21981} DXM has been used in multimodal analgesic therapies for acute and neuropathic pain.{21979,21980}

Territorial Availability: Available through Bertin Technologies only in France

Technical Warning: Bertin Technologies restricts the sale of this product to licensed controlled substance laboratories and qualified academic research institutions. Please contact us for further details.

Special Advice: Please check regulation status before ordering; additionel fees can apply.

  • Synonyms
    • (9?,13?,14?)-3-methoxy-17-methyl-morphinan, hydrobromide monohydrate
  • Correlated keywords
    • 125-71-3 levorphanol codeine morphine antitussive coughs suppressants morphine derivatives NMDA receptors nicotinic calcium channels voltage-gated sodium analgesia pain dextratrorotatory morphinan anti-tussive opioid inhibits inhibitors inhibitions NMDA glutamate multimodal analgesic therapies acute neuropathic analytical references standards
  • Product Overview:
    Dextromethorphan (DXM) is a dextratrorotatory morphinan with structural similarity to levorphanol, codeine, and morphine. Because of its strong antitussive effects, dextromethorphan is widely used as a cough suppressant.{21979} However, it does not provoke opioid activity as is characteristic of several other morphine derivatives. DXM binds to and inhibits NMDA (IC50 = 0.55 ?M) and nicotinic receptors (IC50s = 0.7-3.9 ?M) and blocks receptor-gated and voltage-gated calcium channels (IC50 = 60 ?M) and voltage-gated sodium channels (IC50 = 78 ?M).{21979,21978,21981} DXM has been used in multimodal analgesic therapies for acute and neuropathic pain.{21979,21980}

We also advise you